EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S.
Mar 06, 2017 13:34 pm UTC| Business
EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S. LYON, France, March 6, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the...
OTI Receives 2017 AI Business Excellence Award for Best Cashless Payment Solution Provider
Mar 06, 2017 13:34 pm UTC| Business
ROSH PINNA, Israel, March 06, 2017 -- On Track Innovations Ltd. (OTI) (NASDAQ:OTIV), a global provider of near field communication (NFC) and cashless payment solutions, announced today it has been awarded the 2017 AI...
OTI Receives 2017 AI Business Excellence Award for Best Cashless Payment Solution Provider
Mar 06, 2017 13:34 pm UTC| Business
ROSH PINNA, Israel, March 06, 2017 -- On Track Innovations Ltd. (OTI) (NASDAQ:OTIV), a global provider of near field communication (NFC) and cashless payment solutions, announced today it has been awarded the 2017 AI...
Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017
Mar 06, 2017 13:34 pm UTC| Business
PHILADELPHIA, March 06, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in...
Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017
Mar 06, 2017 13:34 pm UTC| Business
PHILADELPHIA, March 06, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in...
Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017
Mar 06, 2017 13:34 pm UTC| Business
PHILADELPHIA, March 06, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in...
Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017
Mar 06, 2017 13:34 pm UTC| Business
PHILADELPHIA, March 06, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in...